Kylee Maclachlan

48PUBLICATIONS
234CO-AUTHORS
Haematological tumoursMedical bacteriologyGene expression (incl. microarray and other genome-wide approaches)Medical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (48)

|Jul 29, 2026
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.

|Jul 20, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.

|Jun 12, 2026
Genomic features do not account for differences in multiple myeloma risk by ancestry.

|May 01, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients.

|Apr 20, 2026
Whole-genome sequencing of cell-free DNA for assessment of minimal residual disease in high-risk smoldering multiple myeloma.

|Apr 12, 2026
Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi, Tara Sebastian, Sridevi Rajeeve

Pageof 8

Frequent Collaborators

35 joint publications

Malin L Hultcrantz

28 joint publications

Urvi Shah

26 joint publications

Neha Korde

25 joint publications

Saad Z Usmani